Description
Semaglutide is a synthetic GLP-1 receptor agonist designed to mimic the natural hormone glucagon-like peptide-1 (GLP-1), which regulates blood sugar and appetite.
It is a modified peptide with structural changes that make it resistant to enzymatic breakdown. The addition of a C18 fatty acid chain helps it bind to albumin, extending its half-life in the body.
Name: Semaglutide
Type: Synthetic GLP-1 receptor agonist peptide (long-acting analogue of human glucagon-like peptide-1)
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: ≈ 4113.58 g/mol
CAS Number: 910463-68-2
Sequence: 31-amino acid analogue of human GLP-1(7-37)
Structure Type: Synthetic acylated peptide analogue with a fatty-acid side chain and amide-capped C-terminus which is classified as a modified GLP-1 peptide for extended duration of action.
